Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
64.626,85
-0,35%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
01/08/201822:01PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in AugustNASDAQ:BPMCBlueprint Medicines Corporation
01/08/201813:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
01/08/201813:00PR Newswire (US)Blueprint Medicines Reports Second Quarter 2018 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
25/07/201814:00PR Newswire (US)Blueprint Medicines to Report Second Quarter 2018 Financial Results on Wednesday, August 1, 2018NASDAQ:BPMCBlueprint Medicines Corporation
25/06/201822:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
21/06/201814:00PR Newswire (US)Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stroma...NASDAQ:BPMCBlueprint Medicines Corporation
15/06/201814:00PR Newswire (US)Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advan...NASDAQ:BPMCBlueprint Medicines Corporation
04/06/201813:00PR Newswire (US)Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commerci...NASDAQ:BPMCBlueprint Medicines Corporation
31/05/201814:00PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in JuneNASDAQ:BPMCBlueprint Medicines Corporation
17/05/201815:00PR Newswire (US)Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of ...NASDAQ:BPMCBlueprint Medicines Corporation
02/05/201823:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
02/05/201813:00PR Newswire (US)Blueprint Medicines Reports First Quarter 2018 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
27/04/201823:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BPMCBlueprint Medicines Corporation
27/04/201823:56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BPMCBlueprint Medicines Corporation
25/04/201814:00PR Newswire (US)Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018NASDAQ:BPMCBlueprint Medicines Corporation
15/04/201815:35PR Newswire (US)Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Sele...NASDAQ:BPMCBlueprint Medicines Corporation
15/04/201815:30PR Newswire (US)Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Tr...NASDAQ:BPMCBlueprint Medicines Corporation
14/03/201821:35PR Newswire (US)Blueprint Medicines to Present Proof-of-Concept Data from Ongoing Phase 1 Clinical Trial of BLU-667 in Patients with RET-Alte...NASDAQ:BPMCBlueprint Medicines Corporation
06/03/201814:00PR Newswire (US)Blueprint Medicines to Present at Cowen and Company 38th Annual Health Care ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
22/02/201800:00Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BPMCBlueprint Medicines Corporation
22/02/201800:00Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BPMCBlueprint Medicines Corporation
21/02/201813:01PR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
14/02/201820:22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BPMCBlueprint Medicines Corporation
14/02/201814:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
14/02/201814:00PR Newswire (US)Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018NASDAQ:BPMCBlueprint Medicines Corporation
15/12/201722:01PR Newswire (US)Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common ...NASDAQ:BPMCBlueprint Medicines Corporation
13/12/201722:52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BPMCBlueprint Medicines Corporation
13/12/201704:49PR Newswire (US)Blueprint Medicines Announces Pricing of Public Offering of Shares of Common StockNASDAQ:BPMCBlueprint Medicines Corporation
11/12/201722:01PR Newswire (US)Blueprint Medicines Announces Proposed Public Offering of Shares of Common StockNASDAQ:BPMCBlueprint Medicines Corporation
10/12/201714:00PR Newswire (US)Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of Avapritinib (BLU-285) in Patients with Advanced...NASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
FBK
Finecobank
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network